MPM Capital manages $230M and $600M MPM BioVentures family of
venture capital funds that are invested in selected private healthcare
companies in the US and in Europe. These funds are the largest dedicated health care venture capital funds worldwide, focused on private investments in healthcare companies without limitation to specific stage of development. The Company partners with exceptional entrepreneurs, helping them to finance and build companies with the potential to become industry leaders. MPM’s cross functional team with expertise in private equity investing as well as direct operation experience in product development, clinical medicine and biomedical research, enables appropriate investments as well as assistance in all aspects of portfolio company development. MPM Capital typically takes the leading role in the financing, and often anchors a wide syndicate of investors. Company’s strategy is to invest predominantly in biotechnology with a secondary focus on medical devices and pharmaceutical services. Within biotechnology sector, our resources are apportion between
therapeutics and enabling technologies.
MPM Capital LP, has 15 healthcare investment professionals, with
headquarters in Cambridge, MA and offices in San Francisco, CA and Munich, Germany. Together with our Scientific Advisory Board we believe that we have the most comprehensive healthcare team in this arena today.